Diclofenac/Tramadol

双氯芬酸/曲马多

Report date: 2022/07/19 16:22:54

Base Information

Drug NameDiclofenac/Tramadol
Drug Alias NameDiclofenac+Tramadol双氯芬酸+曲马多Tramadol+Diclofenac曲马多+双氯芬酸曲马多/双氯芬酸 +[8
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsMu opioid receptor agonists
TargetsMu opioid receptorCyclooxygenases
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrünenthal GmbH
Active IndicationsN/A
Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A